Dr. Brown joined the team as Senior Advisor of Gordian Life Sciences in 2020. He also currently serves as Chief Executive Officer of Memgen, a biotechnology company based in Houston, TX. Previously, he was the founder of Healthcare Royalty Partners, where he was involved in sourcing, diligencing and closing more than $1 billion of royalty investments. Before co-founding HealthCare Royalty Partners, Dr. Brown was a partner at Paul Capital Partners. Prior to beginning his principal investment career in 2003, Dr. Brown was co-head of investment banking and head of healthcare at Adams, Harkness & Hill (now Canaccord Genuity) and a ranked biotechnology research analyst at Vector Securities International.
Dr. Brown has served on 20 public and private life science company boards, he is educated as a transplantation immunologist and trained as a surgeon. He has practiced thoracic and vascular surgery and founded and led an HMO, and he brings particular expertise in the scientific, technical, clinical and medical evaluation of products as well as in healthcare systems and payor / reimbursement dynamics.
Education/Certifications
Mr. Brown received a B.A. from Yale University, an M.D. from State University of New York Upstate Medical University and his M.B.A. from Harvard Business School.
